Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Recordati Industria Chimica e Farmaceutica SPA (IT:REC)
MILAN:REC
Holding IT:REC?
Track your performance easily
REC Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€43.19 - €54.80
Previous Close€53.75
Volume55.69K
Average Volume (3M)238.75K
Market Cap
€11.09B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)28.6
Beta0.61
Next Earnings
Nov 08, 2024EPS Estimate
€0.68Last Dividend Ex-Date
May 20, 2024Dividend Yield2.24%
Share Statistics
EPS (TTM)1.88
Shares OutstandingN/A
10 Day Avg. Volume241,096
30 Day Avg. Volume238,751
Standard Deviation0.06
R-Squared0.15
Alpha0.00195
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)4.51
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€51.40Price Target Upside-4.06% Downside
Rating ConsensusHold
Number of Analyst Covering5
Recordati Industria Chimica e Farmaceutica SPA News
Options Prices
Currently, No data available
---
Ownership Overview
0.08% Insiders
6.09% Mutual Funds
― Other Institutional Investors
88.55% Public Companies and
Individual Investors
REC FAQ
What was Recordati Industria Chimica e Farmaceutica SPA’s price range in the past 12 months?
Recordati Industria Chimica e Farmaceutica SPA lowest stock price was €43.19 and its highest was €54.80 in the past 12 months.
What is Recordati Industria Chimica e Farmaceutica SPA’s market cap?
Currently, no data Available
When is Recordati Industria Chimica e Farmaceutica SPA’s upcoming earnings report date?
Recordati Industria Chimica e Farmaceutica SPA’s upcoming earnings report date is Nov 08, 2024 which is in 8 days.
How were Recordati Industria Chimica e Farmaceutica SPA’s earnings last quarter?
Recordati Industria Chimica e Farmaceutica SPA released its earnings results on Jul 30, 2024. The company reported €0.67 earnings per share for the quarter, beating the consensus estimate of €0.65 by €0.02.
Is Recordati Industria Chimica e Farmaceutica SPA overvalued?
According to Wall Street analysts Recordati Industria Chimica e Farmaceutica SPA’s price is currently Overvalued.
Does Recordati Industria Chimica e Farmaceutica SPA pay dividends?
Recordati Industria Chimica e Farmaceutica SPA pays a Notavailable dividend of €0.63 which represents an annual dividend yield of 2.24%. See more information on Recordati Industria Chimica e Farmaceutica SPA dividends here
What is Recordati Industria Chimica e Farmaceutica SPA’s EPS estimate?
Recordati Industria Chimica e Farmaceutica SPA’s EPS estimate is €0.68.
How many shares outstanding does Recordati Industria Chimica e Farmaceutica SPA have?
Recordati Industria Chimica e Farmaceutica SPA has 209,125,150 shares outstanding.
What happened to Recordati Industria Chimica e Farmaceutica SPA’s price movement after its last earnings report?
Recordati Industria Chimica e Farmaceutica SPA reported an EPS of €0.67 in its last earnings report, beating expectations of €0.65. Following the earnings report the stock price went down -6.832%.
Which hedge fund is a major shareholder of Recordati Industria Chimica e Farmaceutica SPA?
Currently, no hedge funds are holding shares in IT:REC
---
Recordati Industria Chimica e Farmaceutica SPA Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
25.13%
12-Months-Change
Fundamentals
Return on Equity
22.67%
Trailing 12-Months
Asset Growth
-0.18%
Trailing 12-Months
Company Description
Recordati Industria Chimica e Farmaceutica SPA
Recordati SpA is a drug manufacturing company that focuses on specialty pharmaceuticals. The company produces and promotes medicines globally that focus on primary-care therapies and rare diseases. Recordati uses strategic partnerships as part of its long-term growth strategy. The vast majority of the company's revenue is generated in Italy, followed by France and Germany. Recordati reports two operating segments: specialty and primary care and rare diseases. The bulk of the company's profit is derived from its specialty and primary care segment, which includes the production of active ingredients.
---
REC Stock 12 Month Forecast
Average Price Target
€51.40
▼(-4.06% Downside)
Technical Analysis
Recordati Industria Chimica e Farmaceutica SPA
―
AstraZeneca
―
GlaxoSmithKline
―
Hikma Pharmaceuticals
―
Best Analysts Covering REC
1 Year
1 Year Success Rate
0/8 ratings generated profit
1 Year Average Return
-10.94%
reiterated a sell rating 10 days ago
Copying Charles Pitman CFA's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -10.94% per trade.
---